Clincosm LogoSign in Get a demo

Metastatic Castration-Resistant Prostate Cancer

Showing 1 - 25 of 116
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • HP518 - Dose Escalation
  • HP518 -Dose Expansion
  • (no location specified)
Dec 1, 2023

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Nov 13, 2023

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Oct 23, 2023

Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Carcinoma Trial in

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Oct 19, 2023

Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • New Haven, Connecticut
    Yale Cancer Center
Oct 20, 2023

Metastatic Castration-resistant Prostate Cancer Trial in United States (BMS-986460)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Palo Alto, California
  • +7 more
Oct 10, 2023

Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial (INKmune)

Not yet recruiting
  • Cancer
  • +2 more
  • INKmune
  • (no location specified)
Sep 27, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Finland, Netherlands, United Kingdom (BAY3546828, BAY2616505,

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Helsinki, Finland
  • +3 more
Sep 18, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Bortezomib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Sep 7, 2023

PRostate Olaparib Real World Evidence Study

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
    • (no location specified)
    Sep 4, 2023

    Metastatic Castration-resistant Prostate Cancer Trial (Disitamab Vedotin(RC48-ADC))

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Disitamab Vedotin（RC48-ADC）
    • (no location specified)
    Jul 13, 2023

    Metastatic Castration-resistant Prostate Cancer Trial (ONCT-534)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • (no location specified)
    Jun 15, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in Grand Rapids (SPECT/CT)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • SPECT/CT
    • Grand Rapids, Michigan
      BAMF Health
    Apr 19, 2023

    Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco

    Not yet recruiting
    • Castrate Resistant Prostate Cancer
    • +3 more
    • San Francisco, California
      University of California, San Francisco
    Mar 1, 2023

    Metastatic Castration-resistant Prostate Cancer Trial (Darolutamide, Docetaxel or cabazitaxel)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • (no location specified)
    Feb 28, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in Oslo (212Pb-NG001)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Oslo, Norway
      Oslo University Hospital
    Feb 13, 2023

    Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Glen Burnie (177Lu-rhPSMA-10.1 injection,

    Recruiting
    • Prostate Cancer
    • +5 more
    • 177Lu-rhPSMA-10.1 injection
    • 18F-rhPSMA-7.3 injection
    • Glen Burnie, Maryland
    • +3 more
    Feb 2, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (olaparib, enzalutamide, abiraterone acetate)

    Active, not recruiting
    Has Results
    • Metastatic Castration-resistant Prostate Cancer
    • Anchorage, Alaska
    • +203 more
    Jan 27, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Enfortumab vedotin)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Enfortumab vedotin
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Jan 24, 2023

    Metastatic Castration-resistant Prostate Cancer, Recurrent Epithelial Ovarian Cancer, Breast Cancer Trial (AsiDNA, Olaparib)

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • +2 more
    • (no location specified)
    Jan 17, 2023

    Metastatic Castration-resistant Prostate Cancer Trial in United States (REGN4336, Cemiplimab, 18F-DCFPyL)

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Palo Alto, California
    • +8 more
    Jan 17, 2023

    Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,

    Active, not recruiting
    • Prostatic Neoplasms
    • Metastatic Castration-Resistant Prostate Cancer
    • Abiraterone Acetate
    • +2 more
    • Los Angeles, California
    • +6 more
    Jan 18, 2023

    Metastatic Castration-resistant Prostate Cancer Trial (ONC-392, lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • ONC-392
    • lutetium Lu 177 vipivotide tetraxetan 7.4 GBq (200 mCi), IV infusion, Q6W for up to 6 doses.
    • (no location specified)
    Dec 27, 2022

    Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, NSCLC Trial in Worldwide (CCS1477, Abiraterone

    Recruiting
    • Metastatic Castration-Resistant Prostate Cancer
    • +3 more
    • Boston, Massachusetts
    • +21 more
    Jan 10, 2023

    Metastatic Castration-resistant Prostate Cancer, Androgen Resistant Prostatic Cancer Trial in United States (VERU-111,

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Androgen Resistant Prostatic Cancer
    • Anchorage, Alaska
    • +43 more
    Jan 3, 2023